Bio

Mr. Jahnle co-founded Haverford Healthcare Advisors in 1994 and has over 35 years of transaction advisory and business valuation experience. During his career, Chris has worked on numerous business valuation and transaction advisory engagements involving business entities in the healthcare services industry. He has originated and completed transactions with a combined value in excess of $2.5 billion. In 2006, Mr. Jahnle co-founded Aurora Diagnostics, LLC (www.AuroraDx.com). As one of the largest independent pathology services and cancer diagnostics companies in the U.S., Palm Beach Gardens, FL-based Aurora Diagnostics operates 32 pathology practices in 19 states and employs over 300 pathologists. The company generated pro forma revenue of $310 million for the 12 months ended September 30, 2018. From 2006 through 2018, Haverford initiated and completed 36 acquisitions of pathology practices and laboratories on behalf of Aurora Diagnostics as its exclusive acquisition advisor. Christopher holds a BS in Commerce and Engineering Sciences and an MS in Taxation from Drexel University. His education has been supplemented by numerous continuing professional education courses, including many specific to the healthcare industry.